Riskpilot← Back to searchSign inGet full accessAGC Biologics Copenhagen ApS
APSActiveCVR 39713918Vandtårnsvej 83BActivities of holding companies · NACE 6421Est. 2018— employees
Revenue 2024
—
EBITDA margin
—
+14% vs 2023
Equity ratio
82.3%
Financial strength
Net profit 2024
DKK -21K
+14% vs 2023
| Revenue | — | — |
| EBITDA | DKK -26K | +14% |
| Net profit | DKK -21K | +14% |
| Total assets | DKK 181K | -9% |
| Equity | DKK 149K | -12% |
| Employees | — | — |
Legal name
AGC Biologics Copenhagen ApS
CVR number
39713918
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
25. juni 2018
Share capital
DKK 100.001
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med en direktør, af bestyrelsens formand i forening med 2 bestyrelsesmedlemmer, 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Virksomhedens formål er handel og industri.
Address
Vandtårnsvej 83B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | -28 | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -25 | -19 | -33 | -28 | -27 | -31 | -26 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -25 | -19 | -33 | -28 | -27 | -31 | -26 |
| Net financials | 0 | -0 | 0 | 0 | -1 | 0 | 0 |
| Profit before tax | -25 | -19 | -33 | -28 | -28 | -31 | -26 |
| Tax | -3 | -4 | -7 | -6 | -6 | -7 | -6 |
| Net profit | -22 | -15 | -26 | -22 | -22 | -24 | -21 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 103 | 66 | 50 | 228 | 221 | 198 | 181 |
| Equity | 78 | 63 | 37 | 215 | 193 | 169 | 149 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 3 | 13 | 12 | 28 | 29 | 32 |
| Total debt | 25 | 3 | 13 | 12 | 28 | 29 | 32 |
EBITDA margin
-2635800.0%
This company
15.8%
Market median
-16682378% vs market
20182024
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
20182024
Return on equity
-13.8%
This company
18.4%
Market median
-175% vs market
20182024
Net profit margin
-2055900.0%
This company
8.1%
Market median
-25381581% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-06-25 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Management | Management | 2018 | — | — |
LS Management | Management | 2025 | — | — |
LF Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AGC Biologics A/S | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AGC Biologics A/S
AGC Biologics Copenhagen ApS Board members of AGC Biologics Copenhagen ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kasper Møller | Management | 0 companies |
| Lasse Skov Kristensen | Management | 0 companies |
| Lasse Fuglsang Pedersen | Management | 0 companies |
| Alberto Santagostino | Chairman | 0 companies |
| Gustavo Fabio Mahler | Chairman | 0 companies |
| Hiroshi Nishimura | Board of Directors | 0 companies |
| Akira Nakamura | Board of Directors | 0 companies |
| Noriyuki Komuro | Board of Directors | 0 companies |
| Mai Iwaya | Board of Directors | 0 companies |
| Tadashi Murano | Board of Directors | 0 companies |
| Patricio Ezequiel Massera | Chairman | 0 companies |